Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
Crossref DOI link: https://doi.org/10.1038/s41598-021-98325-w
Published Online: 2021-09-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kamath, Ashwin
Acharya, Sahana D.
Rao, Rashmi R.
Ullal, Sheetal D.
Text and Data Mining valid from 2021-09-22
Version of Record valid from 2021-09-22
Article History
Received: 21 June 2021
Accepted: 7 September 2021
First Online: 22 September 2021
Competing interests
: The authors declare no competing interests.